In-depth study of antiviral RNA silencing in Caenorhabditis elegans
秀丽隐杆线虫抗病毒RNA沉默的深入研究
基本信息
- 批准号:9403202
- 负责人:
- 金额:$ 28.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAnimal ModelAntiviral AgentsAntiviral TherapyBiogenesisBiological ModelsBiological ProcessCaenorhabditis elegansCell Differentiation processCellsDNA Sequence AlterationDetectionDevelopmentDouble-Stranded RNAGene Expression RegulationGene SilencingGenesGeneticGenetic ScreeningHomologous GeneHumanInterferonsInvadedInvertebratesLightLongevityMammalian CellMammalsMediatingMusMutationN-terminalNatural ImmunityNematodaPlantsPlayProteinsRNA HelicaseRNA InterferenceRegulationResearchResistanceRoleSmall Interfering RNAStudy modelsTranscriptUndifferentiatedViralViral Drug ResistanceViral GenomeVirusVirus DiseasesVirus ReplicationWorkantiviral immunityfight againstfungusgene functionhuman diseaseimprovednovelnovel strategiespathogenresponsesensortreatment strategyviral RNAviral detectionvirus development
项目摘要
PROJECT SUMMARY
Antiviral RNA silencing (AvRS), also referred to as antiviral RNA interference (RNAi), acts as
a major antiviral innate mechanism in fungi, plants, and invertebrates. Recent observations suggest that
AvRS is also active in undifferentiated mouse cells and appears to be essential for developing mouse
babies to fight against lethal viral pathogen. Virus destruction in AvRS is guided by small interfering
RNAs derived from viral double-stranded RNAs (dsRNAs), usually the replication intermediates.
Therefore, genetic mutations that accumulate in the viral genome during the term of virus replication
do not confer resistance to AvRS. Hence, mechanistic study of AvRS holds promise for developing
novel strategies for the treatment of viral infection caused human diseases.
In mammals, interferon mediated antiviral immunity represents a major innate immunity against
viral infection. This antiviral immunity is often triggered upon the detection of invading viral RNAs by
three closely related RNA helicases termed RIG-I-like RNA helicases (RLHs). Among these three
RLHs, RIG-I and MDA5 detect virus-produced double-stranded RNAs (dsRNAs) in a sequence-
independent manner and, thus, are also resistant to genetic changes within the viral genome. Thus,
findings from the study of RLH mediated virus detection is also expected to facilitate the development
of novel antiviral therapies. Increasing evidence suggests that RIG-I also plays essential role in
regulating mammal development. Currently, it remains to be an open question how RIG-I regulates
development in mammals
Viruses naturally infect and trigger AvRS in Caenorhabditis elegans, making C. elegans an ideal
model organism for the study of AvRS. Compared to other model organism, C. elegans has so far the
most, in terms of type species, genes identified as key components of AvRS. Because of its short life
span and genetic tractability, C. elegans also allows for rapid identification of novel AvRS genes for
in-depth study of AvRS. More importantly, accumulating evidence suggests that worm RLHs
contribute to both AvRS, by acting as a virus sensor, and worm development. Thus, C. elegans as a
model system would serve us well in addressing the question how the virus detection function of RLHs
is regulated and how RLHs contribute to the regulation of development.
This application seeks to work on (1) genetic and functional characterization of the candidate
AvRS genes isolated from a random genetic screen; (2) mechanistic study of worm AvRS initiation;
(3) mechanistic study of viral transcript destruction by worm AvRS. Findings from the proposed
research are expected to not only improve our understanding of worm AvRS but also facilitate our
study on the regulation of RLH function in virus detection and the regulation of development by RIG-I
in mammals.
项目概要
抗病毒 RNA 沉默 (AvRS),也称为抗病毒 RNA 干扰 (RNAi),其作用如下:
真菌、植物和无脊椎动物的主要抗病毒先天机制。最近的观察表明
AvRS 在未分化的小鼠细胞中也很活跃,并且似乎对于小鼠的发育至关重要
婴儿对抗致命的病毒病原体。 AvRS 中的病毒破坏是由小干扰引导的
源自病毒双链 RNA (dsRNA) 的 RNA,通常是复制中间体。
因此,在病毒复制期间,病毒基因组中积累的基因突变
不赋予 AvRS 抗性。因此,AvRS 的机制研究有望为开发
治疗由病毒感染引起的人类疾病的新策略。
在哺乳动物中,干扰素介导的抗病毒免疫是针对病毒的主要先天免疫。
病毒感染。这种抗病毒免疫通常是在检测到入侵的病毒 RNA 时触发的
三种密切相关的 RNA 解旋酶,称为 RIG-I 样 RNA 解旋酶 (RLH)。这三者之中
RLH、RIG-I 和 MDA5 检测病毒产生的双链 RNA (dsRNA),其序列如下:
独立的方式,因此也能抵抗病毒基因组内的遗传变化。因此,
RLH 介导的病毒检测研究结果也有望促进该技术的发展
的新型抗病毒疗法。越来越多的证据表明 RIG-I 在
调节哺乳动物的发育。目前,RIG-I 如何监管仍然是一个悬而未决的问题
哺乳动物的发育
病毒自然感染秀丽隐杆线虫并引发 AvRS,这使得秀丽隐杆线虫成为理想的选择
AvRS 研究的模型生物。与其他模式生物相比,秀丽隐杆线虫迄今为止
大多数,就模式物种而言,基因被确定为 AvRS 的关键组成部分。由于其寿命短
由于跨度和遗传易处理性,秀丽隐杆线虫还可以快速识别新的 AvRS 基因
深入研究AvRS。更重要的是,越来越多的证据表明蠕虫 RLH
通过充当病毒传感器,对 AvRS 和蠕虫病毒的发展做出贡献。因此,线虫作为
模型系统将很好地帮助我们解决 RLH 的病毒检测功能如何发挥作用的问题
受到监管以及 RLH 如何促进发展监管。
该申请旨在研究 (1) 候选者的遗传和功能特征
从随机遗传筛选中分离出的 AvRS 基因; (2)蠕虫AvRS启动机制研究;
(3)蠕虫AvRS破坏病毒转录本的机制研究。拟议的调查结果
研究预计不仅能增进我们对蠕虫 AvRS 的了解,而且有助于我们
RLH在病毒检测中的功能调控及RIG-I对发育的调控研究
在哺乳动物中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rui Lu其他文献
Rui Lu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rui Lu', 18)}}的其他基金
Negative regulation of human antiviral RNAi by PACT
PACT 对人类抗病毒 RNAi 的负调控
- 批准号:
10667112 - 财政年份:2023
- 资助金额:
$ 28.53万 - 项目类别:
MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia
MEF2D 介导的急性髓系白血病转录控制
- 批准号:
10542726 - 财政年份:2021
- 资助金额:
$ 28.53万 - 项目类别:
MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia
MEF2D 介导的急性髓系白血病转录控制
- 批准号:
10365298 - 财政年份:2021
- 资助金额:
$ 28.53万 - 项目类别:
In-depth study of antiviral RNA silencing in Caenorhabditis elegans
秀丽隐杆线虫抗病毒RNA沉默的深入研究
- 批准号:
9239852 - 财政年份:2017
- 资助金额:
$ 28.53万 - 项目类别:
Cytosolic virus detection in Caenorhabditis elegans
秀丽隐杆线虫胞浆病毒检测
- 批准号:
8824358 - 财政年份:2014
- 资助金额:
$ 28.53万 - 项目类别:
The functional role of DRH-1 in RNAi directed viral immunity
DRH-1 在 RNAi 定向病毒免疫中的功能作用
- 批准号:
8415513 - 财政年份:2012
- 资助金额:
$ 28.53万 - 项目类别:
The functional role of DRH-1 in RNAi directed viral immunity
DRH-1 在 RNAi 定向病毒免疫中的功能作用
- 批准号:
8242983 - 财政年份:2012
- 资助金额:
$ 28.53万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非洲栽培稻抗稻瘟病基因Pi69(t)的功能等位基因克隆及进化解析
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 28.53万 - 项目类别:
The role of beta-cell crinophagy in generating diabetogenic neoepitopes
β细胞吞噬在产生糖尿病新表位中的作用
- 批准号:
10733153 - 财政年份:2023
- 资助金额:
$ 28.53万 - 项目类别:
A community resource for germline and somatic genetic disease modeling in zebrafish
斑马鱼种系和体细胞遗传疾病模型的社区资源
- 批准号:
10723158 - 财政年份:2023
- 资助金额:
$ 28.53万 - 项目类别: